Geode Capital Management’s Firefly Neuroscience AIFF Stock Holding History
Bought
Maintained
Sold
Other funds holding AIFF
M
BFM
CCA
Geode Capital Management's AIFF Position: Q2 2026 in Review
Geode Capital Management reduced its Firefly Neuroscience (AIFF) stake by 22% in Q2 2026, selling an estimated $60.6K and leaving 121,522 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #4011.
Geode Capital Management first reported a position in AIFF in Q1 2022 and has held it in 18 quarters since. The position peaked at $341K in Q2 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.
- Geode Capital Management held 121,522 shares of Firefly Neuroscience worth $147K as of Q2 2026.
- Geode Capital Management sold 34,786 Firefly Neuroscience shares in Q2 2026, an estimated $60.6K.
- Firefly Neuroscience made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4011 holding.
- Geode Capital Management first reported a position in Firefly Neuroscience in Q1 2022 and has held it in 18 quarters since.
- Geode Capital Management's Firefly Neuroscience position peaked at $341K in Q2 2025.
- 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.